Skip to main content Accessibility help
×
Home

Drug induced otalgia due to mesalazine and sulphasalazine

  • Michael Wareing (a1) and David Mitchell (a1)

Abstract

A case of left otalgia in a patient suffering from longstanding ulcerative colitis is reported. The patient was treated for an exacerbation of his disease with courses of mesalazine and sulphasalazine during which time he developed otalgia. The otalgia disappeared with cessation of the drugs. It is concluded that in the absence of any other head and neck cause that the otalgia was a complication of the drug therapy.

Copyright

Corresponding author

Address for correspondence: Mr M. J. Wareing, Department of Otolaryngology, Kent and Canterbury Hospital, Ethelbert Road, Canterbury CT1 3NG.

References

Hide All
Alstead, E. M., Wilson, A. G., Farthing, M. J. (1991) Lichen planus and mesalazine. Journal of Clinical Gastroenterology 13 (3): 335337.
Brimblecombe, R. (1990) Mesalazine: a global safety evaluation. Scandinavian Journal of Gastroenterology 25 (suppl 172): 6668.
Fardy, J. M., Lloyd, D. A., Reynolds, R. P. (1988) Adverse effects with oral 5-aminosalicylic acid. Journal of Clinical Gastroenterology 10 (6): 635637.
Hadjigogos, K. (1991) Unusual side effects of mesalazine. Italian Journal of Gastroenterology 23: 257.
Masson, E. A., Rhodes, J. M. (1992) Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss. Gut 33 (4): 563564.
Pent, M. T., Ganapathy, S., Holdsworth, C. D., Channer, K. C. (1992) Mesalazine induced lupus like syndrome. British Medical Journal 305: 159.
Pullar, T. (1992) Adverse effects of sulphasalazine. Adverse Drug Reaction and Toxicological Reviews 11 (2): 93109.
Reinoso, M. A., Schroeder, K. W., Pisani, R. J. (1992) Lung disease associated with orally administered mesalamine for ulcerative colitis. Chest 101 (5): 14691471.
Ruderman, W. B. (1990) Newer pharmacologic agents for the therapy of inflammatory bowel disease. Medical Clinics of North America 74 (1): 133153.

Keywords

Drug induced otalgia due to mesalazine and sulphasalazine

  • Michael Wareing (a1) and David Mitchell (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed